Amine transporter. Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals. Interacts with PRKCABP. The disease is caused by variants affecting the gene represented in this entry. This protein is the target of psychomotor stimulants such as amphetamines or cocaine. Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family. SLC6A2 subfamily.